Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025)
Autolus Therapeutics posted quarterly Exchange Rate Effect of $589000.0 for Q4 2025, up 101.54% year-on-year from $292247.9 in Q4 2024, and up 116.44% on a QoQ basis from -$3.6 million in Q3 2025.
Autolus Therapeutics (AUTL) has 8 years of Exchange Rate Effect data on file, last reported at $589000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 101.54% year-over-year to $589000.0; the trailing twelve-month figure through Dec 2025 stood at $6.3 million (up 2505.75% YoY), and the FY2025 full-year result was $6.3 million, up 2505.75% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $589000.0, up from -$3.6 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $37.7 million in Q3 2024 and bottomed at -$38.2 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is $1.0 million (2021), against an average of -$404100.0.
- Peak annual rise in Exchange Rate Effect reached 1409.95% in 2022, while the deepest fall reached 1502.55% in 2022.
- A 5-year view of Exchange Rate Effect shows it stood at $734000.0 in 2021, then soared by 1409.95% to $11.1 million in 2022, then dropped by 11.82% to $9.8 million in 2023, then plunged by 491.04% to -$38.2 million in 2024, then jumped by 101.54% to $589000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $589000.0 (Q4 2025), -$3.6 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -900,000.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 589,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 589,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Sep 30, 2025 | -3.58 Mn |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | -38.22 Mn |
| Dec 31, 2024 | -38.22 Mn |
| Sep 30, 2024 | 37.72 Mn |
| Sep 30, 2024 | 37.72 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | -9.30 Mn |
| Sep 30, 2023 | -9.30 Mn |
| Jun 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 7.23 Mn |
| Mar 31, 2023 | 7.33 Mn |
| Mar 31, 2023 | 7.33 Mn |
| Dec 31, 2022 | 11.08 Mn |
| Dec 31, 2022 | 11.08 Mn |
| Sep 30, 2022 | -14.80 Mn |
| Sep 30, 2022 | -14.80 Mn |
| Jun 30, 2022 | -18.68 Mn |
| Jun 30, 2022 | -18.68 Mn |
| Mar 31, 2022 | -5.98 Mn |
| Mar 31, 2022 | -5.98 Mn |
| Dec 31, 2021 | 734,000.00 |
| Dec 31, 2021 | 734,000.00 |
| Sep 30, 2021 | -4.45 Mn |
| Sep 30, 2021 | -4.45 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 1.63 Mn |
| Mar 31, 2021 | 1.63 Mn |
| Dec 31, 2020 | 8.41 Mn |
| Dec 31, 2020 | 8.41 Mn |
| Sep 30, 2020 | 8.75 Mn |
| Sep 30, 2020 | 8.75 Mn |
| Jun 30, 2020 | -1.52 Mn |
| Jun 30, 2020 | -1.52 Mn |
| Mar 31, 2020 | -14.97 Mn |
| Mar 31, 2020 | -14.97 Mn |
| Jun 30, 2019 | -3.38 Mn |
| Jun 30, 2019 | -3.38 Mn |
| Mar 31, 2019 | 4.70 Mn |
| Mar 31, 2019 | 4.70 Mn |
| Sep 30, 2018 | -5.83 Mn |
| Sep 30, 2018 | -5.83 Mn |
| Jun 30, 2018 | -3.89 Mn |
| Jun 30, 2018 | -3.89 Mn |
| Mar 31, 2018 | 4.78 Mn |
| Mar 31, 2018 | 4.78 Mn |